Navigation Links
NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF

CONSHOHOCKEN, Pa., Sept. 10, 2012 /PRNewswire/ -- NextDocs Corporation, the global leader in Microsoft SharePoint-based compliance solutions for the life sciences industry, announced today the launch of Trial Exchange, the newest product available on the NextDocs platform. Trial Exchange provides a simple, consumer-style interface for investigators and site staff to access and contribute documents to the Trial Master File (TMF).

"NextDocs' clinical product line is focused on delivering new innovations to the market. eTMF addressed the internal and partner collaboration challenges and now, with Trial Exchange, we're enabling trial site staff to participate directly in the process," explained Matt Walz, CTO at NextDocs Corporation.  "Trial Exchange does not require training. It has a user experience that feels very consumer, but on the back-end, it is enterprise software and integrates seamlessly with eTMF and other clinical systems."

Trial Exchange solves the challenges that life sciences companies face in managing clinical documents. It allows trial site staff to contribute documents to an established eTMF workstream, receive and complete tasks generated by the sponsor, view document statuses, and retrieve documents on demand. Adopting Trial Exchange can reduce the time and cost of trial management, improve collaboration with investigators, and strengthen document security and compliance.

This new clinical portal allows life sciences companies to:

  • Apply established quality and document management processes to trial site documents
  • Gain visibility into document statuses and due dates and assign tasks to ensure documents are completed properly and on schedule
  • Decrease courier and shipping costs by uploading documents directly to the eTMF
  • Strengthen document security and access for external partners
  • Improve collaboration and relationships with trial site staff

Trial Exchange provides an easy-to-use, streamlined interface for investigators that trial site staff can use with little to no training. Unlike many existing clinical portals, it plugs directly into the eTMF without additional routing, thus applying the sponsor's quality and document management processes to trial site documents.

For more information on Trial Exchange or to register for an upcoming demo of our clinical document management solution, visit

Media Contact:
Kristen Carmean

SOURCE NextDocs Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
2. Faruqi & Faruqi, LLP is Investigating AmerisourceBergen Corporation on Behalf of its Shareholders
3. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
4. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
5. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
6. Luminex Corporation Recognized as Best Technology Company in Austin
7. VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody
8. MGC Diagnostics Corporation Completes Sale of New Leaf Business Assets to Life Time - The Healthy Way of Life Company
9. MGC Diagnostics Corporation Reports Third Quarter Fiscal Year 2012 Operating Results
10. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
11. The Hygenic Corporations Custom Rubber Solutions Solve Industry Problems
Post Your Comments:
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):